On Tuesday, November 2, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) unanimously recommended the Pfizer-BioNTech Covid-19 vaccine for children ages 5–11 under the Federal Drug Administration’s (FDA) emergency use authorization (EUA). With a committee vote of 14–0, CDC Director Rochelle P. Walensky, MD, MPH, endorsed the CDC ACIP recommendation, expanding vaccine recommendations to approximately 28 million children in this age group and allowing providers to begin vaccinating them as soon as possible.